St. Louis, USA, 4th November 2015 / Sciad Newswire / Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and Technology company, today announced it has expanded its distribution agreements with GENEWIZ® and Oxford Genetics to provide customers with an easy-to-use, web-based ordering system that will provide instant pricing for most synthetic DNA up to 5kb. Scientists can now order…

London, UK, and San Francisco, USA, 3rd November 2015 / Sciad Newswire / SynbiCITE, the UK’s national centre for the industrialisation and commercialisation of synthetic biology, is today leading a UKTI trade mission to synthetic biology conference SynBioBeta San Francisco 2015. SynbiCITE, along with 12 of the UK’s leading synthetic biology companies, is headed to San Francisco, USA, to promote…

Ongar, UK, 2nd November 2015 / Sciad Newswire / Selcia has today announced that its spin out company Cypralis has been awarded co-funding by Innovate UK, the UK’s innovation agency, to generate a new class of cyclophilin inhibitors. As part of the deal, Selcia will provide integrated drug discovery services to Cypralis including medicinal chemistry, PPIase screening and ADME….

London, UK, 2nd November 2015 / Sciad Newswire / Canbex Therapeutics Ltd today announced that its novel orally active medication for the treatment of spasticity, VSN16R, has entered a Phase II trial in patients with spasticity caused by multiple sclerosis. The randomized, double-blind, placebo-controlled multi-center trial is being carried out in the UK and aims to enrol 142…

London, UK and Cambridge, UK, 29th October 2015 / Sciad Newswire / Domainex Ltd. announced today that it is expanding all aspects of its drug discovery service business including biology, analytical chemistry and medicinal chemistry. In order to provide the infrastructure required to support this expansion Domainex has signed a long-term lease with Aviva Investors for a laboratory building at…

San Francisco, USA, 26th October 2015 / Sciad Newswire / Ecovative and SynBioBeta announced today that they will be collaborating to provide fungal-derived stage materials including backdrops, decorations, and even chairs for the upcoming SynBioBeta SF 2015 that’s being held on November 4th – 6th at the Mission Bay Conference Center in San Francisco California. The main stage display will be grown by…

London, UK and Cambridge, UK, 20th October 2015 / Sciad Newswire / Domainex Ltd. and Imperial College London today announce a new partnership focused on the discovery of novel therapies to treat myocardial infarction, also known as a heart attack. This follows the success of Imperial in securing £3M in funding from the Wellcome Trust Seeding Drug Discovery programme to…

Belfast, UK, 15th October 2015 / Sciad Newswire / Queen’s University Belfast and Ulster University are joining forces with SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology led by Imperial College London, to deliver a pre-accelerator programme, the Lean LaunchPad aimed at helping local researchers turn their inventions into new products and ventures. The Lean LaunchPad is an import…

Cambridge, UK, 7th October 2015 / Sciad Newswire / Domainex Ltd. is pleased to announce that it is enlisting the support of Shin Kitaoka of BioGemini Ltd. to provide advice on expansion into the Japanese market. Mr Kitaoka has over 35 years of experience in the pharmaceutical industry. He is an expert on drug development in Japan and is a well-known speaker…

London, UK, 5th October 2015 / Sciad Newswire / SynbiCITE and SynBioBeta are gathering with the University of Edinburgh on 6th October to celebrate the opening of the new Centre for Mammalian Synthetic Biology with a special SynBioBeta Activate! event in Edinburgh. Following news that Synthetic Biology companies have raised $500million in funding so far in 2015 (compared to…